Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pulsating electromagnetic field therapy for diabetic foot ulcers

Official title: Evaluating the Efficacy of Pulsating Electromagnetic Field (PEMF) Therapy for Diabetic Foot Ulcers Using the CRAD ULCER X-01 Device: A Randomised Parallel-Group Pilot Study

Run by National Defence University of Malaysia · NCT07465640 · Data updated 2026-11-12

This trial tests whether a PEMF device called CRAD ULCER X-01 helps heal chronic diabetic foot ulcers when added to standard wound care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorNational Defence University of Malaysia
Academic / other
Locations1 site (Kuala Lumpur)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2026
Study endsSeptember 1, 2027
Registry record updatedJuly 28, 2026
Trial IDNCT07465640 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with diabetes and a chronic, non-healing diabetic foot ulcer (Grade I-III, Stage A UT Classification) who consent to participate.

Probably not a fit

Patients with metal implants, pacemakers, malignancies, kidney disease, or other conditions increasing risk may not benefit and could be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the safety and potential efficacy of pulsating electromagnetic field therapy (PEMF) using the CRAD ULCER X-01 device in adults with chronic diabetic foot ulcers. Thirty-two participants with non-healing DFUs are recruited and assigned to a treatment or control group, with all receiving daily wound dressing and standard care; the treatment group uses PEMF for one hour daily. The study aims to see if PEMF can accelerate wound healing, reduce inflammation, and improve outcomes compared with standard care alone. Details on device parameters and full protocol are limited in the provided materials. The trial is conducted at Tuanku Mizan Armed Forces Hospital in Kuala Lumpur, led by the National Defence University of Malaysia.

Why it matters

Potential benefit: If successful, the PEMF treatment could speed up healing of chronic DFUs and reduce complications.

How similar studies have gone: Previous research has suggested PEMF may accelerate wound healing, but results in DFUs are variable and this study explores a specific device and protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of written consent by subjects.
* Subject of either sex.
* At least 18 years of age.
* Known diabetes mellitus.
* Diagnosed with chronic DFU Grade I-III and Stage A according to the University of Texas Classification as recommended in the Malaysian Clinical Practice Guidelines for the Management of Diabetic Foot (2nd Edition).

Exclusion Criteria:

* Inability or unwillingness to provide written consent.
* Inability or unwillingness to comply with the requirements of the protocol as determined by the investigator.
* Other medical conditions which, in the investigator's judgement, may be associated with increased risk to the subject or may interfere with study assessments or outcomes.
* Participation in another clinical trial and/or recipient of investigational therapy within 4 weeks prior to screening visit.
* Patients who have metal implants in any part of the body.
* Patients with a pacemaker.
* History of malignancies.
* Presence of chronic kidney disease co-morbidity.
* Presence of severe peripheral artery disease, assessed when the ankle-brachial index (ABI) is \<0.40.

Where it's running

  • Tuanku Mizan Armed Forces Hospital
    Kuala Lumpur, Malaysia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.